Home
>
National Drug Code (NDC)
>
ZESTRIL
ZESTRIL - 0310-0135-11 - (Lisinopril)
Drug Information of ZESTRIL
| Product NDC: | 0310-0135 |
| Proprietary Name: | ZESTRIL |
| Non Proprietary Name: | Lisinopril |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Lisinopril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZESTRIL
| Product NDC: | 0310-0135 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019777 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110902 |
Package Information of ZESTRIL
| Package NDC: | 0310-0135-11 |
| Package Description: | 100 TABLET in 1 BOTTLE (0310-0135-11) |
NDC Information of ZESTRIL
| NDC Code | 0310-0135-11 |
| Proprietary Name | ZESTRIL |
| Package Description | 100 TABLET in 1 BOTTLE (0310-0135-11) |
| Product NDC | 0310-0135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lisinopril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110902 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | LISINOPRIL |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
